APO Research, Inc.

APO RESEARCH · REPORT

Genotyping Test

Selected research

Market Outlook & Growth Opportunities

Global Genotyping Test Market Outlook and Growth Opportunities 2026

Market perspective

The global Genotyping Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genotyping Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genotyping Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genotyping Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genotyping Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genotyping Test market include Abbott, Thermo Fisher, QIAGEN, Integrated DNA Technologies, Illumina, Fluidigm Corporation, CD Genomics, Biosearch Technologies and Biomerieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genotyping Test market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genotyping Test and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genotyping Test sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genotyping Test market size, projected growth trends, production technologies, key applications, and end-use industries.

Genotyping Test Segment by Company

Abbott

Thermo Fisher

QIAGEN

Integrated DNA Technologies

Illumina

Fluidigm Corporation

CD Genomics

Biosearch Technologies

Biomerieux

Advanced Biological Laboratories

Genotyping Test Segment by Type

Reagents and Kits

Analytical Instruments

Genotyping Test Segment by Application

Diagnostic Research

Pharmacogenomics

Agricultural Biotechnology

Animal Genetics

Genotyping Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genotyping Test status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Genotyping Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genotyping Test significant trends, drivers, influence factors in global and regions.

6. To analyze Genotyping Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genotyping Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genotyping Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genotyping Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genotyping Test market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genotyping Test industry.

Chapter 3: Detailed analysis of Genotyping Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Genotyping Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Genotyping Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genotyping Test Industry Trends Table 2. Genotyping Test Industry Drivers Table 3. Genotyping Test Industry Opportunities and Challenges Table 4. Genotyping Test Industry Restraints Table 5. Global Genotyping Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genotyping Test Revenue Share by Company (2021-2026) Table 7. Global Genotyping Test Sales Volume by Company (k units) & (2021-2026) Table 8. Global Genotyping Test Sales Volume Share by Company (2021-2026) Table 9. Global Genotyping Test Average Price (USD/unit) of Company (2021-2026) Table 10. Global Genotyping Test Company Ranking, (2024-2026) & (USD Million) Table 11. Global Genotyping Test Key Company Manufacturing Base & Headquarters Table 12. Global Genotyping Test Company, Product Type & Application Table 13. Global Genotyping Test Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Genotyping Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Reagents and Kits Table 18. Significant Companies of Analytical Instruments Table 19. Global Genotyping Test Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Genotyping Test Sales Volume by Type (2021-2026) & (k units) Table 21. Global Genotyping Test Sales Volume by Type (2027-2032) & (k units) Table 22. Global Genotyping Test Sales Volume Share by Type (2021-2026) Table 23. Global Genotyping Test Sales Volume Share by Type (2027-2032) Table 24. Global Genotyping Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Genotyping Test Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Genotyping Test Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Genotyping Test Sales Value Share by Type (2021-2026) Table 28. Global Genotyping Test Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Diagnostic Research Table 30. Significant Companies of Pharmacogenomics Table 31. Significant Companies of Agricultural Biotechnology Table 32. Significant Companies of Animal Genetics Table 33. Global Genotyping Test Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Genotyping Test Sales Volume by Application (2021-2026) & (k units) Table 35. Global Genotyping Test Sales Volume by Application (2027-2032) & (k units) Table 36. Global Genotyping Test Sales Volume Share by Application (2021-2026) Table 37. Global Genotyping Test Sales Volume Share by Application (2027-2032) Table 38. Global Genotyping Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Genotyping Test Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Genotyping Test Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Genotyping Test Sales Value Share by Application (2021-2026) Table 42. Global Genotyping Test Sales Value Share by Application (2027-2032) Table 43. Global Genotyping Test Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Genotyping Test Sales by Region (2021-2026) & (k units) Table 45. Global Genotyping Test Sales Market Share by Region (2021-2026) Table 46. Global Genotyping Test Sales by Region (2027-2032) & (k units) Table 47. Global Genotyping Test Sales Market Share by Region (2027-2032) Table 48. Global Genotyping Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Genotyping Test Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Genotyping Test Sales Value Share by Region (2021-2026) Table 51. Global Genotyping Test Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Genotyping Test Sales Value Share by Region (2027-2032) Table 53. Global Genotyping Test Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Genotyping Test Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Genotyping Test Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Genotyping Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Genotyping Test Sales by Country (2021-2026) & (k units) Table 58. Global Genotyping Test Sales Market Share by Country (2021-2026) Table 59. Global Genotyping Test Sales by Country (2027-2032) & (k units) Table 60. Global Genotyping Test Sales Market Share by Country (2027-2032) Table 61. Global Genotyping Test Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Genotyping Test Sales Value Market Share by Country (2021-2026) Table 63. Global Genotyping Test Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Genotyping Test Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Abbott Genotyping Test Product Portfolio Table 69. Abbott Recent Development Table 70. Thermo Fisher Company Information Table 71. Thermo Fisher Business Overview Table 72. Thermo Fisher Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Thermo Fisher Genotyping Test Product Portfolio Table 74. Thermo Fisher Recent Development Table 75. QIAGEN Company Information Table 76. QIAGEN Business Overview Table 77. QIAGEN Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. QIAGEN Genotyping Test Product Portfolio Table 79. QIAGEN Recent Development Table 80. Integrated DNA Technologies Company Information Table 81. Integrated DNA Technologies Business Overview Table 82. Integrated DNA Technologies Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Integrated DNA Technologies Genotyping Test Product Portfolio Table 84. Integrated DNA Technologies Recent Development Table 85. Illumina Company Information Table 86. Illumina Business Overview Table 87. Illumina Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Illumina Genotyping Test Product Portfolio Table 89. Illumina Recent Development Table 90. Fluidigm Corporation Company Information Table 91. Fluidigm Corporation Business Overview Table 92. Fluidigm Corporation Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Fluidigm Corporation Genotyping Test Product Portfolio Table 94. Fluidigm Corporation Recent Development Table 95. CD Genomics Company Information Table 96. CD Genomics Business Overview Table 97. CD Genomics Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. CD Genomics Genotyping Test Product Portfolio Table 99. CD Genomics Recent Development Table 100. Biosearch Technologies Company Information Table 101. Biosearch Technologies Business Overview Table 102. Biosearch Technologies Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Biosearch Technologies Genotyping Test Product Portfolio Table 104. Biosearch Technologies Recent Development Table 105. Biomerieux Company Information Table 106. Biomerieux Business Overview Table 107. Biomerieux Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Biomerieux Genotyping Test Product Portfolio Table 109. Biomerieux Recent Development Table 110. Advanced Biological Laboratories Company Information Table 111. Advanced Biological Laboratories Business Overview Table 112. Advanced Biological Laboratories Genotyping Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Advanced Biological Laboratories Genotyping Test Product Portfolio Table 114. Advanced Biological Laboratories Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Genotyping Test Distributors List Table 118. Genotyping Test Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Genotyping Test Product Image Figure 2. Global Genotyping Test Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genotyping Test Sales Value (2021-2032) & (US$ Million) Figure 4. Global Genotyping Test Sales (2021-2032) & (k units) Figure 5. Global Genotyping Test Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Genotyping Test Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Reagents and Kits Image Figure 10. Analytical Instruments Image Figure 11. Global Genotyping Test Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Genotyping Test Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Genotyping Test Sales Volume Share by Type (2021-2032) Figure 14. Global Genotyping Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Genotyping Test Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Genotyping Test Sales Value Share by Type (2021-2032) Figure 17. Diagnostic Research Image Figure 18. Pharmacogenomics Image Figure 19. Agricultural Biotechnology Image Figure 20. Animal Genetics Image Figure 21. Global Genotyping Test Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Genotyping Test Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Genotyping Test Sales Volume Share by Application (2021-2032) Figure 24. Global Genotyping Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Genotyping Test Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Genotyping Test Sales Value Share by Application (2021-2032) Figure 27. Global Genotyping Test Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Genotyping Test Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Genotyping Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Genotyping Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Genotyping Test Sales Value (2021-2032) & (US$ Million) Figure 32. North America Genotyping Test Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Genotyping Test Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Genotyping Test Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Genotyping Test Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Genotyping Test Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Genotyping Test Sales Value (2021-2032) & (US$ Million) Figure 38. South America Genotyping Test Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Genotyping Test Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Genotyping Test Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Genotyping Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Genotyping Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Genotyping Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Genotyping Test Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Genotyping Test Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Reagents and Kits
  • Analytical Instruments
Applications
  • Diagnostic Research
  • Pharmacogenomics
  • Agricultural Biotechnology
  • Animal Genetics
Companies covered
  • Abbott
  • Thermo Fisher
  • QIAGEN
  • Integrated DNA Technologies
  • Illumina
  • Fluidigm Corporation
  • CD Genomics
  • Biosearch Technologies
  • Biomerieux
  • Advanced Biological Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genotyping Test Sales Value (2021-2032)
  4. 1.2.2 Global Genotyping Test Sales Volume (2021-2032)
  5. 1.2.3 Global Genotyping Test Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Genotyping Test Market Dynamics
  1. 2.1 Genotyping Test Industry Trends
  2. 2.2 Genotyping Test Industry Drivers
  3. 2.3 Genotyping Test Industry Opportunities and Challenges
  4. 2.4 Genotyping Test Industry Restraints
3 Genotyping Test Market by Company
  1. 3.1 Global Genotyping Test Company Revenue Ranking in 2025
  2. 3.2 Global Genotyping Test Revenue by Company (2021-2026)
  3. 3.3 Global Genotyping Test Sales Volume by Company (2021-2026)
  4. 3.4 Global Genotyping Test Average Price by Company (2021-2026)
  5. 3.5 Global Genotyping Test Company Ranking (2024-2026)
  6. 3.6 Global Genotyping Test Company Manufacturing Base and Headquarters
  7. 3.7 Global Genotyping Test Company Product Type and Application
  8. 3.8 Global Genotyping Test Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Genotyping Test Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Genotyping Test Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Genotyping Test Market by Type
  1. 4.1 Genotyping Test Type Introduction
  2. 4.1.1 Reagents and Kits
  3. 4.1.2 Analytical Instruments
  4. 4.2 Global Genotyping Test Sales Volume by Type
  5. 4.2.1 Global Genotyping Test Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Genotyping Test Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Genotyping Test Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Genotyping Test Sales Value by Type
  9. 4.3.1 Global Genotyping Test Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Genotyping Test Sales Value by Type (2021-2032)
  11. 4.3.3 Global Genotyping Test Sales Value Share by Type (2021-2032)
5 Genotyping Test Market by Application
  1. 5.1 Genotyping Test Application Introduction
  2. 5.1.1 Diagnostic Research
  3. 5.1.2 Pharmacogenomics
  4. 5.1.3 Agricultural Biotechnology
  5. 5.1.4 Animal Genetics
  6. 5.2 Global Genotyping Test Sales Volume by Application
  7. 5.2.1 Global Genotyping Test Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Genotyping Test Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Genotyping Test Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Genotyping Test Sales Value by Application
  11. 5.3.1 Global Genotyping Test Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Genotyping Test Sales Value by Application (2021-2032)
  13. 5.3.3 Global Genotyping Test Sales Value Share by Application (2021-2032)
6 Genotyping Test Regional Sales and Value Analysis
  1. 6.1 Global Genotyping Test Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genotyping Test Sales by Region (2021-2032)
  3. 6.2.1 Global Genotyping Test Sales by Region: 2021-2026
  4. 6.2.2 Global Genotyping Test Sales by Region (2027-2032)
  5. 6.3 Global Genotyping Test Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Genotyping Test Sales Value by Region (2021-2032)
  7. 6.4.1 Global Genotyping Test Sales Value by Region: 2021-2026
  8. 6.4.2 Global Genotyping Test Sales Value by Region (2027-2032)
  9. 6.5 Global Genotyping Test Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Genotyping Test Sales Value (2021-2032)
  12. 6.6.2 North America Genotyping Test Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Genotyping Test Sales Value (2021-2032)
  15. 6.7.2 Europe Genotyping Test Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Genotyping Test Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Genotyping Test Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Genotyping Test Sales Value (2021-2032)
  21. 6.9.2 South America Genotyping Test Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Genotyping Test Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Genotyping Test Sales Value Share by Country, 2025 VS 2032
7 Genotyping Test Country-level Sales and Value Analysis
  1. 7.1 Global Genotyping Test Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genotyping Test Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Genotyping Test Sales by Country (2021-2032)
  4. 7.3.1 Global Genotyping Test Sales by Country (2021-2026)
  5. 7.3.2 Global Genotyping Test Sales by Country (2027-2032)
  6. 7.4 Global Genotyping Test Sales Value by Country (2021-2032)
  7. 7.4.1 Global Genotyping Test Sales Value by Country (2021-2026)
  8. 7.4.2 Global Genotyping Test Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Genotyping Test Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Genotyping Test Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Genotyping Test Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Genotyping Test Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Genotyping Test Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Genotyping Test Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Genotyping Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Genotyping Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Genotyping Test Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Genotyping Test Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Genotyping Test Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Genotyping Test Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Genotyping Test Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Genotyping Test Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Genotyping Test Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Genotyping Test Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Genotyping Test Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Genotyping Test Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Genotyping Test Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Genotyping Test Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Genotyping Test Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Genotyping Test Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Genotyping Test Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Genotyping Test Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Genotyping Test Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Genotyping Test Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Genotyping Test Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Genotyping Test Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Genotyping Test Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Genotyping Test Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Genotyping Test Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Genotyping Test Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Genotyping Test Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Genotyping Test Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Genotyping Test Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Genotyping Test Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Genotyping Test Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Genotyping Test Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Genotyping Test Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Genotyping Test Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Genotyping Test Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Genotyping Test Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Genotyping Test Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Genotyping Test Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Genotyping Test Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Genotyping Test Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Genotyping Test Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Genotyping Test Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Genotyping Test Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Genotyping Test Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Genotyping Test Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Genotyping Test Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Genotyping Test Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Genotyping Test Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Genotyping Test Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Genotyping Test Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Genotyping Test Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Genotyping Test Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Genotyping Test Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Genotyping Test Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Genotyping Test Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Genotyping Test Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Genotyping Test Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Genotyping Test Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Genotyping Test Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Genotyping Test Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Genotyping Test Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Genotyping Test Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Genotyping Test Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Genotyping Test Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Genotyping Test Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Genotyping Test Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Genotyping Test Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Genotyping Test Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Genotyping Test Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Genotyping Test Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Genotyping Test Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Genotyping Test Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Genotyping Test Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Genotyping Test Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Genotyping Test Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Genotyping Test Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Genotyping Test Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Genotyping Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Genotyping Test Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Genotyping Test Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Genotyping Test Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Genotyping Test Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 QIAGEN
  14. 8.3.1 QIAGEN Company Information
  15. 8.3.2 QIAGEN Business Overview
  16. 8.3.3 QIAGEN Genotyping Test Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 QIAGEN Genotyping Test Product Portfolio
  18. 8.3.5 QIAGEN Recent Developments
  19. 8.4 Integrated DNA Technologies
  20. 8.4.1 Integrated DNA Technologies Company Information
  21. 8.4.2 Integrated DNA Technologies Business Overview
  22. 8.4.3 Integrated DNA Technologies Genotyping Test Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Integrated DNA Technologies Genotyping Test Product Portfolio
  24. 8.4.5 Integrated DNA Technologies Recent Developments
  25. 8.5 Illumina
  26. 8.5.1 Illumina Company Information
  27. 8.5.2 Illumina Business Overview
  28. 8.5.3 Illumina Genotyping Test Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Illumina Genotyping Test Product Portfolio
  30. 8.5.5 Illumina Recent Developments
  31. 8.6 Fluidigm Corporation
  32. 8.6.1 Fluidigm Corporation Company Information
  33. 8.6.2 Fluidigm Corporation Business Overview
  34. 8.6.3 Fluidigm Corporation Genotyping Test Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fluidigm Corporation Genotyping Test Product Portfolio
  36. 8.6.5 Fluidigm Corporation Recent Developments
  37. 8.7 CD Genomics
  38. 8.7.1 CD Genomics Company Information
  39. 8.7.2 CD Genomics Business Overview
  40. 8.7.3 CD Genomics Genotyping Test Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CD Genomics Genotyping Test Product Portfolio
  42. 8.7.5 CD Genomics Recent Developments
  43. 8.8 Biosearch Technologies
  44. 8.8.1 Biosearch Technologies Company Information
  45. 8.8.2 Biosearch Technologies Business Overview
  46. 8.8.3 Biosearch Technologies Genotyping Test Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Biosearch Technologies Genotyping Test Product Portfolio
  48. 8.8.5 Biosearch Technologies Recent Developments
  49. 8.9 Biomerieux
  50. 8.9.1 Biomerieux Company Information
  51. 8.9.2 Biomerieux Business Overview
  52. 8.9.3 Biomerieux Genotyping Test Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Biomerieux Genotyping Test Product Portfolio
  54. 8.9.5 Biomerieux Recent Developments
  55. 8.10 Advanced Biological Laboratories
  56. 8.10.1 Advanced Biological Laboratories Company Information
  57. 8.10.2 Advanced Biological Laboratories Business Overview
  58. 8.10.3 Advanced Biological Laboratories Genotyping Test Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Advanced Biological Laboratories Genotyping Test Product Portfolio
  60. 8.10.5 Advanced Biological Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genotyping Test Value Chain Analysis
  2. 9.1.1 Genotyping Test Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genotyping Test Sales Mode & Process
  6. 9.2 Genotyping Test Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genotyping Test Distributors
  9. 9.2.3 Genotyping Test Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.